Monday August 20, 2018
The Food and Drug Administration (FDA) is strengthening the
current warnings in the prescribing information that
fluoroquinolone antibiotics may cause significant decreases in
blood sugar and certain mental health side effects. The low blood
sugar levels can result in serious problems, including coma,
particularly in older people and patients with diabetes who are
taking medicines to reduce blood sugar. We are making these changes
because our recent review found reports of life-threatening low
blood sugar side effects and reports of additional mental health
side effects.
Please click on the link bellow to review more on this
topic:
https://www.fda.gov/Drugs/DrugSafety/ucm611032.htm